AGTHX
Price
$88.58
Change
-$0.29 (-0.33%)
Updated
Jun 2 closing price
Net Assets
337.53B
USLCX
Price
$29.73
Change
-$0.30 (-1.00%)
Updated
Jun 2 closing price
Net Assets
1.27B
Interact to see
Advertisement

AGTHX vs USLCX

Header iconAGTHX vs USLCX Comparison
Open Charts AGTHX vs USLCXBanner chart's image
AGTHX vs USLCX Comparison Chart in %
View a ticker or compare two or three
VS
AGTHX vs. USLCX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGTHX is a Hold and USLCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AGTHX has more cash in the bank: 338B vs. USLCX (1.27B). AGTHX pays higher dividends than USLCX: AGTHX (0.25) vs USLCX (0.00). AGTHX was incepted earlier than USLCX: AGTHX (53 years) vs USLCX (24 years). USLCX (1.89) is less costly to investors than AGTHX (0.59). AGTHX (32.00) and USLCX (32.00) have comparable annual turnover. AGTHX has a lower initial minimum investment than USLCX: AGTHX (250) vs USLCX (1000). AGTHX annual gain was more profitable for investors over the last year : 15.06 vs. USLCX (-31.77). AGTHX return over 5 years is better than : 25.59 vs. USLCX (-41.79).
AGTHXUSLCXAGTHX / USLCX
Total Expense Ratio0.591.8831%
Annual Report Gross Expense Ratio0.591.8931%
Fund Existence53 years24 years-
Gain YTD10.452-0.826-1,266%
Front Load6%N/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets338B1.27B26,551%
Annual Yield % from dividends0.250.00-
Returns for 1 year15.06-31.77-47%
Returns for 3 years53.87-26.43-204%
Returns for 5 years25.59-41.79-61%
Returns for 10 years114.32-16.49-693%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSHAX12.600.20
+1.61%
NYLI Cushing® MLP Premier Class A
RYOAX61.16N/A
N/A
Rydex Biotechnology H
SWTSX18.32N/A
N/A
Schwab Total Stock Market Index
PHSKX37.47N/A
N/A
Virtus KAR Mid-Cap Growth A
JLPYX25.76N/A
N/A
JPMorgan US Large Cap Core Plus R6